Novel Synthesis of 4- or 6-Substituted Indirubin Derivatives

REFERENCES

• Xiao , Z. J. ; Hao , Y. S. ; Liu , B. C. ; Qian , L. S. Indirubin and meisoindigo in the treatment of chromic myelogenous leukemia in China . Leuk. Lymph. 2002 , 43 , 1763 – 1768 .
   PubMed Web of Science ®Google Scholar
• Ji , X. J. ; Zhang , F. R. ; Lei , J. L. ; Xu , Y. T. Studies on the antineoplastic action and toxicity of synthetic indirubin . Acta Pharmaceutica Sinica. 1981 , 16 , 146 – 148 .
   PubMedGoogle Scholar
• Ji , X. J. ; Liu , X. M. ; Li , K. ; Chen , R. H. ; Wang , L. G. Pharmacological studies of meisoindigo: Absorption and mechanism of action . Biomed. Environ. Sci. 1991 , 4 , 332 – 337 .
   PubMedGoogle Scholar
• Yu , H. ; Jove , R. The STATs of cancer—New molecular targets come of age . Nat. Rev. Cancer 2004 , 4 , 97 – 105 .
   PubMed Web of Science ®Google Scholar
• Kim , S.-A. ; Kim , Y.-C. ; Kim , S.-W. ; Lee , S.-H. ; Min , J.-J. ; Ahn , S.-G. ; Yoon , J.-H. Antitumor activity of novel indirubin derivatives in rat tumor model . Clin. Cancer Res. 2007 , 13 , 253 – 259 .
   PubMed Web of Science ®Google Scholar
• Tang , W. ; Hemm , I. ; Bertram , B. Recent development of antitumor agents from Chinese herbal medicines, part I: Low molecular compounds . Planta Med. 2003 , 69 , 97 – 108 .
   PubMed Web of Science ®Google Scholar
• Libnow , S. ; Methling , K. ; Hein , M. ; Michalik , D. ; Harms , M. ; Wende , K. ; Flemming , A. ; Köckerling , M. ; Reinke , H. ; Bednarski , P. J. ; Lalk , M. ; Langer , P. Synthesis of indirubin-N′-glycosides and their anti-proliferative activity against human cancer cell lines . Bioorgan. Med. Chem. 2008 , 16 , 5570 – 5583 .
   PubMed Web of Science ®Google Scholar
• Perabo , F. G. E. ; Frössler , C. ; Landwehrs , G. ; Schmidt , D. H. ; Von Rücker , A. ; Wirger , A. ; Müller , S. C. Indirubin-3′-monoxime, a CDK inhibitor induces growth inhibition and apoptosis-independent up-regulation of survivin in transitional cell cancer . Anticancer Res. 2006 , 26 ( 3A ), 2129 – 2135 .
   PubMedGoogle Scholar
• Polychronopoulos , P. ; Magiatis , P. ; Skaltsounis , A. L. ; Myrianthopoulos , V. ; Mikros , E. ; Tarricone , A. ; Musacchio , A. ; Roe , S. M. ; Pearl , L. ; Leost , M. ; Greengard , P. ; Meijer , L. Structural basis for the synthesis of indirubins as potent and selective inhibitors of glycogen synthase kinase-3 and cyclin-dependent kinases . J. Med. Chem. 2004 , 47 , 935 – 946 .
   PubMed Web of Science ®Google Scholar
• Hoessel , R. ; Leclerc , S. ; Endicott , J. A. ; Nobel , M. E. M. ; Lawrie , A. ; Tunnah , P. ; Leost , M. ; Damiens , E. ; Marie , D. ; Marko , D. ; Niederberger , E. ; Tang , W. ; Eisenbrand , G. ; Meijer , L. Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases. Nat. Cell Biol. 1999, 1, 60–67.
   PubMed Web of Science ®Google Scholar
• Davies , T. G. ; Tunnah , P. ; Meijer , L. ; Marko , D. ; Eisenbrand , G. ; Endicott , J. A. ; Noble , M. E. M. Inhibitor binding to active and inactive CDK2: The crystal structure of CDK2-cyclin A/indirubin-5-sulphonate . Structure 2001 , 9 , 389 – 397 .
   PubMed Web of Science ®Google Scholar
• Marko , D. ; Schätzle , S. ; Friedel , A. ; Genzlinger , A. ; Zankl , H. ; Meijer , L. ; Eisenbrand , G. Inhibition of cyclin-dependent kinase 1 (CDK1) by indirubin derivatives in human tumour cells . Br. J. Cancer. 2001 , 84 ( 2 ), 283 – 289 .
   PubMed Web of Science ®Google Scholar
• Hoessel , R. ; Leclerc , S. ; Endicott , J. A. ; Nobel , M. E. M. ; Lawrie , A. ; Tunnah , P. ; Leost , M. ; Damiens , E. ; Marie , D. ; Marko , D. ; Niederberger , E. ; Tang , W. ; Eisenbrand , G. ; Meijer , L. Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclindependent kinases . Nat. Cell Biol. 1999 , 1 , 60 – 67 .
   PubMed Web of Science ®Google Scholar
• Leclerc , S. ; Garnier , M. ; Hoessel , R. ; Marko , D. ; Bibb , J. A. ; Snyder , G. L. ; Greengard , P. ; Biernat , J. ; Wu , Y.-Z. ; Mandekowi , E.-M. ; Eisenbrand , G. ; Meijer , L. Indirubins inhibit glycogen synthase kinase-3β and CDK5/p25, two kinases involved in abnormal tau phosphorylation in Alzheimer's disease, a property common to most CDK inhibitors . J. Biol. Chem. 2001 , 276 ( 1 ), 251 – 260 .
   PubMed Web of Science ®Google Scholar
• Meijer , L. ; Skaltsounis , A.-L. ; Magiantis , P. ; Polychromopoulos , P. ; Knockaert , M. ; Leost , M. ; Ryan , X. P. ; Vonica , C. A. ; Brivanlou , A. ; Dajani , R. ; Crovace , C. ; Tarricone , C. ; Musacchio , A. ; Roe , S. M. ; Pearl , L. ; Greengard , P. GSK-3 selective inhibitors derived from Tyrian purple indirubins . Chem. Biol. 2003 , 10 , 1255 – 1266 .
   PubMed Web of Science ®Google Scholar
• Moon , M. J. ; Lee , S. K. ; Lee , J. W. ; Song , W. K. ; Kim , S. W. ; Kim , J. I. ; Cho , C. ; Choi , S. J. ; Kim , Y. C. Synthesis and structure–activity relationships of novel indirubin derivatives as potent anti-proliferative agents with CDK2 inhibitory activities . Bioorgan. Med. Chem. 2006 , 14 , 237 – 246 .
   PubMed Web of Science ®Google Scholar
• Tanoue , Y. ; Hara , A. ; Kai , N. ; Sakata , K. ; Hashimoto , M. ; Nagai , T. A revised synthetic scheme of 6, 6′-dibromoindirubin . J. Heterocycl. Chem. 2007 , 44 , 1135 – 1137 .
   Google Scholar
• Wu , Z.-L. ; Aryal , P. ; Lozach , O. ; Meijer , L. ; Guengerich , F. P. Biosynthesis of new indigoid inhibitors of protein kinases using recombinant cytochrome P450 2A6 . Chem. Biodivers. 2005 , 2 , 51 – 65 .
   PubMed Web of Science ®Google Scholar
• Guengerich , F. P. ; Sorrells , J. L. ; Schmitt , S. ; Krauser , J. A. ; Aryal , P. ; Meijer , L. Generation of new protein kinase inhibitors utilizing cytochrome P450 mutant enzymes for indigoid synthesis . J. Med. Chem. 2004 , 47 , 3236 – 3241 .
   PubMed Web of Science ®Google Scholar
• Guha , S. K. ; Mitra , A. K. Indigoid vat dyes of the isatin series, part XIII: 3-Indole-2′-(6′-bromo)thionaphthene-indoigos . J. Indian Chem. Soc. 1967 , 44 , 694 – 696 .
   Google Scholar
• Wang , Z. H. ; Li , W. Y. ; Li , F. L. ; Zhang , L. ; Hua , W. Y. ; Cheng , J. C. ; Yao , Q. Z. Synthesis and antitumor activity of 7-azaindirubin . Chin. Chem. Lett. 2009 , 20 , 542 – 544 .
   Google Scholar
• Wu , K.-M. ; Zhang , M.-Y. ; Fang , Z. ; Huang , L. Potential antileukemic agents: Synthesis of derivatives of indirubin, indigo, and isoindigotin . Acta Pharm. Sin. 1985 , 20 , 821 – 826 .
   Google Scholar